First, they indicate that a partial reduction in expression and/or haploinsufficiency of the NOTCH2NLC, LRP12, and GIPC1 genes are not associated with overt clinical manifestations, dismissing the hypothesis of a loss of function mechanism in OPDM and NIID. The gene discussed is LRP12; the disease is neuronal intranuclear inclusion disease.